Bank of the West’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,657
Closed -$305K 230
2021
Q2
$305K Sell
1,657
-343
-17% -$63.1K 0.03% 197
2021
Q1
$306K Sell
2,000
-43
-2% -$6.58K 0.03% 192
2020
Q4
$319K Sell
2,043
-577
-22% -$90.1K 0.04% 186
2020
Q3
$300K Sell
2,620
-650
-20% -$74.4K 0.04% 181
2020
Q2
$367K Sell
3,270
-2,539
-44% -$285K 0.05% 190
2020
Q1
$521K Sell
5,809
-17,989
-76% -$1.61M 0.08% 172
2019
Q4
$2.57M Sell
23,798
-8,926
-27% -$965K 0.3% 88
2019
Q3
$3.21M Sell
32,724
-2,117
-6% -$207K 0.39% 74
2019
Q2
$4.56M Buy
34,841
+1,384
+4% +$181K 0.54% 51
2019
Q1
$4.52M Buy
33,457
+304
+0.9% +$41.1K 0.53% 52
2018
Q4
$3.23M Buy
33,153
+3,092
+10% +$301K 0.39% 76
2018
Q3
$4.18M Sell
30,061
-7,984
-21% -$1.11M 0.49% 62
2018
Q2
$4.72M Buy
38,045
+2,809
+8% +$349K 0.58% 50
2018
Q1
$3.93M Sell
35,236
-2,238
-6% -$249K 0.49% 63
2017
Q4
$4.48M Sell
37,474
-11,144
-23% -$1.33M 0.56% 60
2017
Q3
$6.82M Sell
48,618
-526
-1% -$73.8K 0.86% 35
2017
Q2
$5.98M Buy
49,144
+2,067
+4% +$252K 0.77% 38
2017
Q1
$5.71M Buy
47,077
+3,909
+9% +$474K 0.72% 44
2016
Q4
$5.28M Sell
43,168
-5,986
-12% -$732K 0.73% 43
2016
Q3
$6.02M Buy
49,154
+5,710
+13% +$700K 0.83% 32
2016
Q2
$5.07M Buy
43,444
+3,585
+9% +$419K 0.72% 38
2016
Q1
$5.55M Buy
39,859
+3,256
+9% +$453K 0.77% 34
2015
Q4
$6.98M Buy
36,603
+3,531
+11% +$674K 0.97% 26
2015
Q3
$5.17M Buy
33,072
+861
+3% +$135K 0.82% 32
2015
Q2
$5.82M Buy
32,211
+8,076
+33% +$1.46M 0.83% 37
2015
Q1
$4.18M Buy
24,135
+1,058
+5% +$183K 0.59% 54
2014
Q4
$4.27M Buy
23,077
+183
+0.8% +$33.9K 0.62% 54
2014
Q3
$3.8M Buy
22,894
+704
+3% +$117K 0.64% 53
2014
Q2
$3.47M Buy
22,190
+625
+3% +$97.7K 0.54% 70
2014
Q1
$3.28M Sell
21,565
-1,191
-5% -$181K 0.54% 65
2013
Q4
$3.02M Sell
22,756
-513
-2% -$68.2K 0.48% 70
2013
Q3
$2.7M Sell
23,269
-1,613
-6% -$187K 0.49% 71
2013
Q2
$2.3M Buy
+24,882
New +$2.3M 0.43% 80